Drug-Eluting Balloons

Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon

The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral artery disease (PAD) for the superficial femoral and popliteal arteries in the upper leg....

Medtron IN-PACT SFA Trial, drug-eluted balloons

For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral ...

C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035 drug-coated balloon (DCB) catheter for percutaneous transluminal angioplasty (PTA) after pre-dilatation, for the treatment of de novo or restenotic l...

Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath

Boston Scientific received CE mark for the Ranger Paclitaxel-coated PTA Balloon Catheter. The technology is now in full European market launch. 

drug-eluting balloons, DEB, ECRI, report, peripheral artery disease, PAD, cath
ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology, “Health Technology Forecast report, "Drug-eluting...
Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon (DCB). 
Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon
The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral...
balloon catheters, clinical trial/study, medtronic, IN.PACT Admiral drug-coated
The results of a landmark study published this month in Circulation indicate that a device from Medtronic Inc. called the IN.PACT Admiral drug-coated balloon (...
Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon
Medtronic’s In.Pact Admiral drug-coated balloon (DCB) is for the interventional treatment of peripheral artery disease (PAD) for the
The Lutonix 035 drug-coated balloon (DCB) catheter is for percutaneous transluminal angioplasty (PTA) after pre-dilatation, for the...

Articles

drug-eluting balloons, DEB, ECRI, report, peripheral artery disease, PAD, cath
ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology, “Health Technology Forecast report, "Drug-eluting...
Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon, DEB
The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral...
For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug-coated balloon from Medtronic Inc....
FDA Clears Lutonix 035 Drug Coated Balloon C.R. Bard Inc.
C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035 drug-coated balloon (DCB) catheter for percutaneous...

Video Center

The silence is deafening. And since radiology associations, physician groups and vendors have yet...
2 days 16 hours ago
The America College of Cardiology has released its list of key late-breaking clinical trials at the...
1 week 3 days ago
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict...
4 weeks 3 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...

Comparison Charts

Sorry there is no data available